Loading...

Leonardo Iaccarino, PhD

Title(s)Postdoctoral Scholar, Neurology
SchoolSchool of Medicine
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Sala A, Caminiti SP, Iaccarino L, Beretta L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D. Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies. Hum Brain Mapp. 2019 Oct 15; 40(15):4537-4550. PMID: 31322307.
      View in: PubMed
    2. Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimers Dement. 2019 Aug; 15(8):1081-1103. PMID: 31230910.
      View in: PubMed
    3. Iaccarino L, Sala A, Perani D. Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET. Ann Clin Transl Neurol. 2019 Jun; 6(6):1113-1120. PMID: 31211176.
      View in: PubMed
    4. Ossenkoppele R, Iaccarino L, Schonhaut DR, Brown JA, La Joie R, O'Neil JP, Janabi M, Baker SL, Kramer JH, Gorno-Tempini ML, Miller BL, Rosen HJ, Seeley WW, Jagust WJ, Rabinovici GD. Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain. Neuroimage Clin. 2019; 23:101848. PMID: 31077982.
      View in: PubMed
    5. Perani D, Iaccarino L, Jacobs AH. Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies. Alzheimers Dement (Amst). 2019 Dec; 11:327-332. PMID: 31080871.
      View in: PubMed
    6. Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther. 2019 Feb 23; 11(1):20. PMID: 30797240.
      View in: PubMed
    7. Sala A, Iaccarino L, Fania P, Vanoli EG, Fallanca F, Pagnini C, Cerami C, Calvo A, Canosa A, Pagani M, Chiò A, Cistaro A, Perani D. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging. 2019 May; 46(5):1117-1131. PMID: 30617963.
      View in: PubMed
    8. Perani D, Lalli S, Iaccarino L, Alongi P, Gambini O, Franzini A, Albanese A. Prefrontal Cortical Stimulation in Tourette Disorder: Proof-of-concept Clinical and Neuroimaging Study. Mov Disord Clin Pract. 2018 Sep-Oct; 5(5):499-505. PMID: 30515438.
      View in: PubMed
    9. Presotto L, Iaccarino L, Sala A, Vanoli EG, Muscio C, Nigri A, Bruzzone MG, Tagliavini F, Gianolli L, Perani D, Bettinardi V. Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification. Neuroimage Clin. 2018; 20:153-160. PMID: 30094164.
      View in: PubMed
    10. Iaccarino L, Sala A, Caminiti SP, Santangelo R, Iannaccone S, Magnani G, Perani D. The brain metabolic signature of visual hallucinations in dementia with Lewy bodies. Cortex. 2018 11; 108:13-24. PMID: 30098477.
      View in: PubMed
    11. Santos-Santos MA, Rabinovici GD, Iaccarino L, Ayakta N, Tammewar G, Lobach I, Henry ML, Hubbard I, Mandelli ML, Spinelli E, Miller ZA, Pressman PS, O'Neil JP, Ghosh P, Lazaris A, Meyer M, Watson C, Yoon SJ, Rosen HJ, Grinberg L, Seeley WW, Miller BL, Jagust WJ, Gorno-Tempini ML. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia. JAMA Neurol. 2018 03 01; 75(3):342-352. PMID: 29309493.
      View in: PubMed
    12. Belloli S, Zanotti L, Murtaj V, Mazzon C, Di Grigoli G, Monterisi C, Masiello V, Iaccarino L, Cappelli A, Poliani PL, Politi LS, Moresco RM. 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis. J Neuroinflammation. 2018 Feb 05; 15(1):33. PMID: 29402285.
      View in: PubMed
    13. Alongi P, Iaccarino L, Losa M, Del Vecchio A, Gerevini S, Plebani V, Di Muzio N, Mortini P, Gianolli L, Perani D. PET Evaluation of Late Cerebral Effect in Advanced Radiation Therapy Techniques for Cranial Base Tumors. Curr Radiopharm. 2018; 11(2):86-91. PMID: 29804540.
      View in: PubMed
    14. Iaccarino L, Presotto L, Bettinardi V, Gianolli L, Roiter I, Capellari S, Parchi P, Cortelli P, Perani D. An in vivo 11C-PK PET study of microglia activation in Fatal Familial Insomnia. Ann Clin Transl Neurol. 2018 01; 5(1):11-18. PMID: 29376088.
      View in: PubMed
    15. Iaccarino L, Sala A, Caminiti SP, Perani D. The emerging role of PET imaging in dementia. F1000Res. 2017; 6:1830. PMID: 29071066.
      View in: PubMed
    16. Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Neuroimage Clin. 2018; 17:452-464. PMID: 29159058.
      View in: PubMed
    17. Cerami C, Iaccarino L, Perani D. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging. Int J Mol Sci. 2017 May 05; 18(5). PMID: 28475165.
      View in: PubMed
    18. Iaccarino L, Moresco RM, Presotto L, Bugiani O, Iannaccone S, Giaccone G, Tagliavini F, Perani D. An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease. Mol Neurobiol. 2018 Apr; 55(4):2856-2868. PMID: 28455699.
      View in: PubMed
    19. Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. J Alzheimers Dis. 2017; 59(2):603-614. PMID: 28671117.
      View in: PubMed
    20. Ballarini T, Iaccarino L, Magnani G, Ayakta N, Miller BL, Jagust WJ, Gorno-Tempini ML, Rabinovici GD, Perani D. Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease. Hum Brain Mapp. 2016 12; 37(12):4234-4247. PMID: 27412866.
      View in: PubMed
    21. Iaccarino L, Marelli S, Iannaccone S, Magnani G, Ferini-Strambi L, Perani D. Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies. J Alzheimers Dis. 2016 04 05; 52(3):989-97. PMID: 27060952.
      View in: PubMed
    22. Ambra FI, Iavarone A, Ronga B, Chieffi S, Carnevale G, Iaccarino L, Cimminella F, Chiavazzo A, Garofalo E. Qualitative patterns at Raven's colored progressive matrices in mild cognitive impairment and Alzheimer's disease. Aging Clin Exp Res. 2016 Jun; 28(3):561-5. PMID: 26296535.
      View in: PubMed
    23. Iaccarino L, Crespi C, Della Rosa PA, Catricalà E, Guidi L, Marcone A, Tagliavini F, Magnani G, Cappa SF, Perani D. The semantic variant of primary progressive aphasia: clinical and neuroimaging evidence in single subjects. PLoS One. 2015; 10(3):e0120197. PMID: 25756991.
      View in: PubMed
    24. Alongi P, Iaccarino L, Perani D. PET Neuroimaging: Insights on Dystonia and Tourette Syndrome and Potential Applications. Front Neurol. 2014; 5:183. PMID: 25295029.
      View in: PubMed
    25. Chieffi S, Iavarone A, Iaccarino L, La Marra M, Messina G, De Luca V, Monda M. Age-related differences in distractor interference on line bisection. Exp Brain Res. 2014 Nov; 232(11):3659-64. PMID: 25092273.
      View in: PubMed
    26. Perani D, Daniela P, Schillaci O, Orazio S, Padovani A, Alessandro P, Nobili FM, Mariano NF, Iaccarino L, Leonardo I, Della Rosa PA, Pasquale Anthony DR, Frisoni G, Giovanni F, Caltagirone C, Carlo C. A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis. Biomed Res Int. 2014; 2014:785039. PMID: 24772437.
      View in: PubMed
    27. Iaccarino L, Chieffi S, Iavarone A. Utilization behavior: what is known and what has to be known? Behav Neurol. 2014; 2014:297128. PMID: 24825954.
      View in: PubMed